"Globally, more than 130 million people are estimated to be living with Hepatitis C. Left untreated, the disease can be deadly. But sofosbuvir, released in late 2013 by U.S. biopharmaceutical firmGilead (GILD), is effectively a cure.
It's also expensive, costing $84,000 for a 12-week course in the U.S. Doctors often prescribe the drug -- sold under the brand names Sovaldi and Harvoni -- in combination with others, further raising the overall cost of treatment.
As a result, insurers and government healthcare providers often pay for its use in only their sickest patients.
But in India, a 12-week course of the drug's generic version can be purchased for just $500"
Link to CNN Money Full Article
The $83,500 savings would more than offset the plane fare, lodging and mandatory vacation!
It's also expensive, costing $84,000 for a 12-week course in the U.S. Doctors often prescribe the drug -- sold under the brand names Sovaldi and Harvoni -- in combination with others, further raising the overall cost of treatment.
As a result, insurers and government healthcare providers often pay for its use in only their sickest patients.
But in India, a 12-week course of the drug's generic version can be purchased for just $500"
Link to CNN Money Full Article
The $83,500 savings would more than offset the plane fare, lodging and mandatory vacation!
RSS Feed
